Oppenheimer upgraded Inspire Medical (INSP) to Outperform from Perform with a $175 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target raised to $165 from $135 at Piper Sandler
- Inspire Medical price target raised to $180 from $125 at Baird
- Teradyne upgraded, Circle Internet initiated: Wall Street’s top analyst calls
- Inspire Medical downgraded to Equal Weight at Morgan Stanley on slowing growth
- Inspire Medical downgraded to Equal Weight from Overweight at Morgan Stanley